Tracon Pharmaceuticals' Series A Round

Tracon Pharmaceuticals raised a round of funding on April 06, 2011.

Tracon Pharmaceuticals develops targeted therapies for cancer and age-related macular degeneration. Tracon's current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin a…

Articles about Tracon Pharmaceuticals' Series A Round: